Zantac 75 Efferdose

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved March 1998

Specific Treatments:

heartburn

Find Related Trials for The Following Conditions

General Information

Zantac 75 Efferdose has been approved for the treatment of heartburn. It is the first over-the-counter effervescent H2 antagonist.